{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T22:27:10Z","timestamp":1788992830702,"version":"build-2803163510"},"reference-count":106,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T00:00:00Z","timestamp":1759622400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005357","name":"Agent\u00fara na Podporu V\u00fdskumu a V\u00fdvoja","doi-asserted-by":"publisher","award":["APVV-21-0108"],"award-info":[{"award-number":["APVV-21-0108"]}],"id":[{"id":"10.13039\/501100005357","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005357","name":"Agent\u00fara na Podporu V\u00fdskumu a V\u00fdvoja","doi-asserted-by":"publisher","award":["APVV-PP-COVID-20-0010"],"award-info":[{"award-number":["APVV-PP-COVID-20-0010"]}],"id":[{"id":"10.13039\/501100005357","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ejps.2025.107312","type":"journal-article","created":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:06:51Z","timestamp":1759795611000},"page":"107312","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["SARS-CoV-2 N7-methyltransferase inhibitors: Towards selective and potent antivirals"],"prefix":"10.1016","volume":"214","author":[{"given":"Katarina","family":"Sujova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9378-5860","authenticated-orcid":false,"given":"Vladimir","family":"Frecer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2025.107312_bib0001","unstructured":"4 Therapeutics for COVID-19 | COVID-19 rapid guideline: Managing COVID-19 | Guidance | NICE. (2021, March 23). NICE. https:\/\/www.nice.org.uk\/guidance\/ng191\/chapter\/4-Therapeutics-for-COVID-19#antivirals."},{"key":"10.1016\/j.ejps.2025.107312_bib0002","doi-asserted-by":"crossref","first-page":"m3379","DOI":"10.1136\/bmj.m3379","article-title":"A living WHO guideline on drugs for covid-19","volume":"370","author":"Agarwal","year":"2020","journal-title":"BMJ"},{"issue":"21","key":"10.1016\/j.ejps.2025.107312_bib0003","doi-asserted-by":"crossref","DOI":"10.1002\/ejoc.202101481","article-title":"Bisubstrate strategies to target methyltransferases","volume":"2022","author":"Ahmed-Belkacem","year":"2022","journal-title":"Eur. J. Org. Chem."},{"issue":"41","key":"10.1016\/j.ejps.2025.107312_bib0004","doi-asserted-by":"crossref","first-page":"17692","DOI":"10.1039\/D4NJ02481H","article-title":"Synthesis of acyclic analogues of adenosine sulfonamides and their activity against RNA cap guanine N7-methyltransferase of SARS-CoV-2","volume":"48","author":"Ahmed-Belkacem","year":"2024","journal-title":"New J. Chem."},{"issue":"8","key":"10.1016\/j.ejps.2025.107312_bib0005","doi-asserted-by":"crossref","first-page":"6231","DOI":"10.1021\/acs.jmedchem.2c00120","article-title":"Potent inhibition of SARS-CoV-2 nsp14 N7-methyltransferase by sulfonamide-based bisubstrate analogues","volume":"65","author":"Ahmed-Belkacem","year":"2022","journal-title":"J. Med. Chem."},{"issue":"38","key":"10.1016\/j.ejps.2025.107312_bib0006","doi-asserted-by":"crossref","first-page":"6486","DOI":"10.1002\/ejoc.201901120","article-title":"Synthesis of adenine dinucleosides 2\u2032,5\u2032-bridged by sulfur-containing linkers as bisubstrate SAM analogues for viral RNA 2\u2032-O-methyltransferases","volume":"2019","author":"Ahmed-Belkacem","year":"2019","journal-title":"Eur. J. Org. Chem."},{"key":"10.1016\/j.ejps.2025.107312_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.107035","article-title":"5\u2019-cap RNA\/SAM mimetic conjugates as bisubstrate inhibitors of viral RNA cap 2\u2019-O-methyltransferases","volume":"143","author":"Ahmed-Belkacem","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejps.2025.107312_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112557","article-title":"Synthesis of adenine dinucleosides SAM analogs as specific inhibitors of SARS-CoV nsp14 RNA cap guanine-N7-methyltransferase","volume":"201","author":"Ahmed-Belkacem","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"3","key":"10.1016\/j.ejps.2025.107312_bib0009","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1039\/D3MD00737E","article-title":"N-arylsulfonamide-based adenosine analogues to target RNA cap N7-methyltransferase nsp14 of SARS-CoV-2","volume":"15","author":"Ahmed-Belkacem","year":"2024","journal-title":"RSC Med. Chem."},{"issue":"8","key":"10.1016\/j.ejps.2025.107312_bib0010","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1038\/s41591-024-03173-6","article-title":"Long COVID science, research and policy","volume":"30","author":"Al-Aly","year":"2024","journal-title":"Nat. Med."},{"issue":"38","key":"10.1016\/j.ejps.2025.107312_bib0011","doi-asserted-by":"crossref","first-page":"7582","DOI":"10.1039\/D2OB01569B","article-title":"Facile access to 4\u2032-(N-acylsulfonamide) modified nucleosides and evaluation of their inhibitory activity against SARS-CoV-2 RNA cap N7-guanine-methyltransferase nsp14","volume":"20","author":"Amador","year":"2022","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejps.2025.107312_bib0012","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.antiviral.2017.06.021","article-title":"Toward the identification of viral cap-methyltransferase inhibitors by fluorescence screening assay","volume":"144","author":"Aouadi","year":"2017","journal-title":"Antivir. Res."},{"issue":"16","key":"10.1016\/j.ejps.2025.107312_bib0013","doi-asserted-by":"crossref","first-page":"4495","DOI":"10.1021\/ja017588+","article-title":"Theoretical study on the stability of N-glycosyl bonds: why does N7-platination not promote depurination?","volume":"124","author":"Baik","year":"2002","journal-title":"J. Am. Chem. Soc."},{"issue":"13","key":"10.1016\/j.ejps.2025.107312_bib0014","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1042\/BCJ20210219","article-title":"Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of Nsp14 RNA cap methyltransferase","volume":"478","author":"Basu","year":"2021","journal-title":"Biochem. J."},{"issue":"7","key":"10.1016\/j.ejps.2025.107312_bib0015","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1021\/acsmedchemlett.1c00140","article-title":"Potent SARS-CoV-2 mRNA cap methyltransferase inhibitors by bioisosteric replacement of methionine in SAM cosubstrate","volume":"12","author":"Bobi\u013ceva","year":"2021","journal-title":"ACS Med. Chem. Lett."},{"issue":"2","key":"10.1016\/j.ejps.2025.107312_bib0016","doi-asserted-by":"crossref","first-page":"768","DOI":"10.3390\/molecules28020768","article-title":"3-(Adenosylthio)benzoic acid derivatives as SARS-CoV-2 Nsp14 methyltransferase inhibitors","volume":"28","author":"Bobileva","year":"2023","journal-title":"Molecules"},{"issue":"12","key":"10.1016\/j.ejps.2025.107312_bib0017","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.3390\/ph14121243","article-title":"Discovery of SARS-CoV-2 Nsp14 and Nsp16 methyltransferase inhibitors by high-throughput virtual screening","volume":"14","author":"Bobrovs","year":"2021","journal-title":"Pharmaceuticals"},{"issue":"4","key":"10.1016\/j.ejps.2025.107312_bib0018","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000863","article-title":"In vitro reconstitution of SARS-coronavirus mRNA cap methylation","volume":"6","author":"Bouvet","year":"2010","journal-title":"PLoS Pathog."},{"issue":"3","key":"10.1016\/j.ejps.2025.107312_bib0019","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1021\/acsinfecdis.3c00356","article-title":"Development of Pan-Anti-SARS-CoV-2 agents through allosteric inhibition of nsp14\/nsp10 complex","volume":"10","author":"Chen","year":"2024","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ejps.2025.107312_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107894","article-title":"Identification of adenosine analogues as nsp14 N7\u2011methyltransferase inhibitors for treating coronaviruses infection","volume":"153","author":"Chen","year":"2024","journal-title":"Bioorg. Chem."},{"issue":"9","key":"10.1016\/j.ejps.2025.107312_bib0021","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1073\/pnas.0808790106","article-title":"Functional screen reveals SARS coronavirus nonstructural protein nsp14 as a novel cap N7 methyltransferase","volume":"106","author":"Chen","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ejps.2025.107312_bib0022","unstructured":"COVID - Coronavirus Statistics\u2014Worldometer. Retrieved 28 October 2024, from https:\/\/www.worldometers.info\/coronavirus\/."},{"key":"10.1016\/j.ejps.2025.107312_bib0023","unstructured":"COVID-19 medicines | European Medicines Agency (EMA). Retrieved 9 November 2024, from https:\/\/www.ema.europa.eu\/en\/human-regulatory-overview\/public-health-threats\/coronavirus-disease-covid-19\/covid-19-medicines."},{"issue":"8","key":"10.1016\/j.ejps.2025.107312_bib0024","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.str.2022.04.014","article-title":"Refolding of lid subdomain of SARS-CoV-2 nsp14 upon nsp10 interaction releases exonuclease activity","volume":"30","author":"Czarna","year":"2022","journal-title":"Structure"},{"issue":"1","key":"10.1016\/j.ejps.2025.107312_bib0025","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nrmicro2675","article-title":"Conventional and unconventional mechanisms for capping viral mRNA","volume":"10","author":"Decroly","year":"2012","journal-title":"Nat. Rev. Microbiol."},{"issue":"9","key":"10.1016\/j.ejps.2025.107312_bib0026","first-page":"1200","article-title":"Probing the SAM binding site of SARS-CoV-2 Nsp14 in vitro using SAM competitive inhibitors guides developing selective bisubstrate inhibitors","volume":"26","author":"Devkota","year":"2021","journal-title":"SLAS Discov. Adv. Life Sci. R&D"},{"issue":"10","key":"10.1016\/j.ejps.2025.107312_bib0027","doi-asserted-by":"crossref","first-page":"365","DOI":"10.14745\/ccdr.v50i10a05","article-title":"Large scale analysis of the SARS-CoV-2 main protease reveals marginal presence of nirmatrelvir-resistant SARS-CoV-2 Omicron mutants in Ontario, Canada, December 2021-September 2023","volume":"50","author":"Duvvuri","year":"2024","journal-title":"Can. Commun. Dis. Rep."},{"issue":"24","key":"10.1016\/j.ejps.2025.107312_bib0028","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24244492","article-title":"Methyltransferase inhibitors: competing with, or exploiting the bound cofactor","volume":"24","author":"Ferreira de Freitas","year":"2019","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.ejps.2025.107312_bib0029","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.antiviral.2012.07.007","article-title":"The viral RNA capping machinery as a target for antiviral drugs","volume":"96","author":"Ferron","year":"2012","journal-title":"Antivir. Res."},{"issue":"2","key":"10.1016\/j.ejps.2025.107312_bib0030","doi-asserted-by":"crossref","first-page":"E162","DOI":"10.1073\/pnas.1718806115","article-title":"Structural and molecular basis of mismatch correction and ribavirin excision from coronavirus RNA","volume":"115","author":"Ferron","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"10453","key":"10.1016\/j.ejps.2025.107312_bib0031","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0140-6736(24)01136-X","article-title":"Long COVID: a clinical update","volume":"404","author":"Greenhalgh","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.ejps.2025.107312_bib0032","article-title":"In silico structure modelling of SARS-CoV-2 Nsp13 helicase and Nsp14 and repurposing of FDA approved antiviral drugs as dual inhibitors","volume":"21","author":"Gurung","year":"2020","journal-title":"Gene Rep."},{"issue":"4","key":"10.1016\/j.ejps.2025.107312_bib0033","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1021\/acscentsci.2c00369","article-title":"The path to paxlovid","volume":"8","author":"Halford","year":"2022","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.ejps.2025.107312_bib0034","doi-asserted-by":"crossref","DOI":"10.1021\/acs.biochem.4c00490","article-title":"A high-throughput screening pipeline to identify methyltransferase and exonuclease inhibitors of SARS-CoV-2 NSP14","author":"Hanson","year":"2025","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejps.2025.107312_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2023.107899","article-title":"SARS-CoV-2 NSP14 governs mutational instability and assists in making new SARS-CoV-2 variants","volume":"170","author":"Hassan","year":"2024","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.ejps.2025.107312_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115474","article-title":"Structure-guided optimization of adenosine mimetics as selective and potent inhibitors of coronavirus nsp14 N7-methyltransferases","volume":"256","author":"Hausdorff","year":"2023","journal-title":"Eur. J. Med. Chem."},{"issue":"8","key":"10.1016\/j.ejps.2025.107312_bib0037","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1021\/acscentsci.3c00538","article-title":"Naturally occurring mutations of SARS-CoV-2 main protease confer drug resistance to Nirmatrelvir","volume":"9","author":"Hu","year":"2023","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.ejps.2025.107312_bib0038","unstructured":"IDSA Guidelines on the Treatment and Management of Patients with COVID-19. Retrieved 9 November 2024, from https:\/\/www.idsociety.org\/practice-guideline\/covid-19-guideline-treatment-and-management\/."},{"issue":"7944","key":"10.1016\/j.ejps.2025.107312_bib0039","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/s41586-022-05514-2","article-title":"Multiple pathways for SARS-CoV-2 resistance to nirmatrelvir","volume":"613","author":"Iketani","year":"2022","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ejps.2025.107312_bib0040","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/nar\/gkac1207","article-title":"Crystal structures and fragment screening of SARS-CoV-2 NSP14 reveal details of exoribonuclease activation and mRNA capping and provide starting points for antiviral drug development","volume":"51","author":"Imprachim","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejps.2025.107312_bib0041","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104559","article-title":"Global prevalence of SARS-CoV-2 3CL protease mutations associated with nirmatrelvir or ensitrelvir resistance","volume":"91","author":"Ip","year":"2023","journal-title":"EBioMedicine"},{"issue":"2","key":"10.1016\/j.ejps.2025.107312_bib0042","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/wrna.43","article-title":"The RNA capping machinery as an anti-infective target","volume":"2","author":"Issur","year":"2011","journal-title":"WIREs RNA"},{"issue":"9","key":"10.1016\/j.ejps.2025.107312_bib0043","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1021\/acsmedchemlett.2c00265","article-title":"Bisubstrate inhibitors of severe acute Respiratory syndrome coronavirus-2 Nsp14 methyltransferase","volume":"13","author":"Jung","year":"2022","journal-title":"ACS Med. Chem. Lett."},{"issue":"24","key":"10.1016\/j.ejps.2025.107312_bib0044","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202400618","article-title":"Structural basis for inhibition of the SARS-CoV-2 nsp16 by substrate-based dual site inhibitors","volume":"19","author":"Kalnins","year":"2024","journal-title":"ChemMedChem"},{"issue":"3","key":"10.1016\/j.ejps.2025.107312_bib0045","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s13577-021-00512-4","article-title":"COVID-19 vaccines: rapid development, implications, challenges and future prospects","volume":"34","author":"Kashte","year":"2021","journal-title":"Hum. Cell"},{"key":"10.1016\/j.ejps.2025.107312_bib0046","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2021.105142","article-title":"Identification and evaluation of potential SARS-CoV-2 antiviral agents targeting mRNA cap guanine N7-methyltransferase","volume":"193","author":"Kasprzyk","year":"2021","journal-title":"Antivir. Res."},{"issue":"10","key":"10.1016\/j.ejps.2025.107312_bib0047","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.1039\/D4MD00422A","article-title":"Discovery of highly potent SARS-CoV-2 nsp14 methyltransferase inhibitors based on adenosine 5\u2019-carboxamides","volume":"15","author":"Kocek","year":"2024","journal-title":"RSC Med. Chem."},{"issue":"9","key":"10.1016\/j.ejps.2025.107312_bib0048","doi-asserted-by":"crossref","DOI":"10.1038\/s41594-022-00828-1","article-title":"High-resolution structures of the SARS-CoV-2 N7-methyltransferase inform therapeutic development","volume":"29","author":"Kottur","year":"2022","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"7","key":"10.1016\/j.ejps.2025.107312_bib0049","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1011546","article-title":"Structures of SARS-CoV-2 N7-methyltransferase with DOT1L and PRMT7 inhibitors provide a platform for new antivirals","volume":"19","author":"Kottur","year":"2023","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ejps.2025.107312_bib0050","unstructured":"Lagevrio | European Medicines Agency. Retrieved 2 January 2024, from https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/lagevrio."},{"issue":"31","key":"10.1016\/j.ejps.2025.107312_bib0051","doi-asserted-by":"crossref","first-page":"30451","DOI":"10.18632\/oncotarget.5860","article-title":"DOT1L: a new therapeutic target for aggressive breast cancer","volume":"6","author":"Lee","year":"2015","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.ejps.2025.107312_bib0052","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1038\/s41467-025-56651-x","article-title":"Distal protein-protein interactions contribute to nirmatrelvir resistance","volume":"16","author":"Lewandowski","year":"2025","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.ejps.2025.107312_bib0053","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbagen.2023.130319","article-title":"SS148 and WZ16 inhibit the activities of nsp10-nsp16 complexes from all seven human pathogenic coronaviruses","volume":"1867","author":"Li","year":"2023","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"issue":"6","key":"10.1016\/j.ejps.2025.107312_bib0054","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/s41573-023-00672-y","article-title":"Therapeutic strategies for COVID-19: progress and lessons learned","volume":"22","author":"Li","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"issue":"3","key":"10.1016\/j.ejps.2025.107312_bib0055","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.pharmthera.2014.03.007","article-title":"Epigenetic targets and drug discovery: part 1: histone methylation","volume":"143","author":"Liu","year":"2014","journal-title":"Pharmacol. Ther."},{"issue":"30","key":"10.1016\/j.ejps.2025.107312_bib0056","doi-asserted-by":"crossref","first-page":"9436","DOI":"10.1073\/pnas.1508686112","article-title":"Structural basis and functional analysis of the SARS coronavirus nsp14-nsp10 complex","volume":"112","author":"Ma","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"11","key":"10.1016\/j.ejps.2025.107312_bib0057","doi-asserted-by":"crossref","first-page":"4670","DOI":"10.1021\/acs.jproteome.0c00397","article-title":"Repurposing of FDA-approved toremifene to treat COVID-19 by blocking the spike glycoprotein and NSP14 of SARS-CoV-2","volume":"19","author":"Martin","year":"2020","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.ejps.2025.107312_bib0058","doi-asserted-by":"crossref","DOI":"10.1002\/cpt.2646","article-title":"Recommendations for the management of drug\u2013drug interactions between the COVID-19 antiviral nirmatrelvir\/ritonavir (Paxlovid) and comedications","author":"Marzolini","year":"2022","journal-title":"Clin. Pharmacol. Ther."},{"issue":"8048","key":"10.1016\/j.ejps.2025.107312_bib0059","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/s41586-024-08320-0","article-title":"Small-molecule inhibition of SARS-CoV-2 NSP14 RNA cap methyltransferase","volume":"637","author":"Meyer","year":"2025","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.ejps.2025.107312_bib0060","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.3390\/v14081790","article-title":"SARS-CoV-2 nsp14 exoribonuclease removes the natural antiviral 3\u2019-deoxy-3\u2019,4\u2019-didehydro-cytidine nucleotide from RNA","volume":"14","author":"Moeller","year":"2022","journal-title":"Viruses."},{"issue":"2","key":"10.1016\/j.ejps.2025.107312_bib0061","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1093\/nar\/gkab1279","article-title":"Coronaviral RNA-methyltransferases: function, structure and inhibition","volume":"50","author":"Nencka","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejps.2025.107312_bib0062","doi-asserted-by":"crossref","unstructured":"Nigam, A., Hurley, M.F.D., Li, F., Konko\u013eov\u00e1, E., Kl\u00edma, M., Tryl\u010dov\u00e1, J., Pollice, R., \u00c7inaro\u011flu, S.S., Levin-Konigsberg, R., Handjaya, J., Schapira, M., Chau, I., Perveen, S., Ng, H.-L., \u00dcmit Kaniskan, H., Han, Y., Singh, S., Gorgulla, C., Kundaje, A., Jin, J., Voelz, V. A., Weber, J., Nencka, R., Boura, E., Vedadi, M., & Aspuru-Guzik, A., 2024. Drug Discovery in Low Data Regimes: Leveraging a Computational Pipeline for the Discovery of Novel SARS-CoV-2 Nsp14-MTase Inhibitors. bioRxiv: The Preprint Server for Biology, 2023.10.03.560722. doi:10.1101\/2023.10.03.560722.","DOI":"10.1101\/2023.10.03.560722"},{"issue":"49","key":"10.1016\/j.ejps.2025.107312_bib0063","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2108709118","article-title":"Structure\u2013function analysis of the nsp14 N7\u2013guanine methyltransferase reveals an essential role in betacoronavirus replication","volume":"118","author":"Ogando","year":"2021","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"8","key":"10.1016\/j.ejps.2025.107312_bib0064","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1021\/acsinfecdis.1c00131","article-title":"The structure-based design of SARS-CoV-2 nsp14 methyltransferase ligands yields nanomolar inhibitors","volume":"7","author":"Otava","year":"2021","journal-title":"ACS Infect. Dis."},{"issue":"5","key":"10.1016\/j.ejps.2025.107312_bib0065","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1021\/acsptsci.5c00111","article-title":"Discovery of SARS-CoV-2 Nsp14-methyltransferase (MTase) inhibitors by harnessing scaffold-centric exploration of the ultra large chemical space","volume":"8","author":"Pal","year":"2025","journal-title":"ACS Pharmacol. Transl. Sci."},{"issue":"12","key":"10.1016\/j.ejps.2025.107312_bib0066","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/s41551-020-00658-w","article-title":"Development of vaccines and antivirals for combating viral pandemics","volume":"4","author":"Pardi","year":"2020","journal-title":"Nat. Biomed. Eng."},{"issue":"7928","key":"10.1016\/j.ejps.2025.107312_bib0067","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/s41586-022-05185-z","article-title":"The mechanism of RNA capping by SARS-CoV-2","volume":"609","author":"Park","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.ejps.2025.107312_bib0068","unstructured":"Paxlovid | European Medicines Agency. Retrieved 2 January 2024, from https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/paxlovid."},{"issue":"6","key":"10.1016\/j.ejps.2025.107312_bib0069","first-page":"749","article-title":"Development of a high-throughput screening assay to identify inhibitors of the SARS-CoV-2 guanine-N7-methyltransferase using RapidFire mass spectrometry","volume":"26","author":"Pearson","year":"2021","journal-title":"SLAS Discov. Adv. Life Sci. R&D"},{"issue":"1","key":"10.1016\/j.ejps.2025.107312_bib0070","doi-asserted-by":"crossref","first-page":"4509","DOI":"10.1038\/s41598-024-55184-5","article-title":"Kinetic characterization of human mRNA guanine-N7 methyltransferase","volume":"14","author":"Perveen","year":"2024","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.ejps.2025.107312_bib0071","doi-asserted-by":"crossref","DOI":"10.3390\/microbiolres14030068","article-title":"Antiviral potential of Antillogorgia americana and elisabethae Natural Products against nsp16\u2013nsp10 complex, nsp13, and nsp14 proteins of SARS-CoV-2: an in silico investigation","volume":"14","author":"Pokharkar","year":"2023","journal-title":"Microbiol. Res."},{"key":"10.1016\/j.ejps.2025.107312_bib0072","unstructured":"Post COVID-19 condition (Long COVID). Retrieved 8 November 2024, from https:\/\/www.who.int\/europe\/news-room\/fact-sheets\/item\/post-covid-19-condition."},{"issue":"12","key":"10.1016\/j.ejps.2025.107312_bib0073","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.1016\/S0021-9258(17)34682-3","article-title":"Sinefungin, a potent inhibitor of virion mRNA(guanine-7-)-methyltransferase, mRNA(nucleoside-2\u2019-)-methyltransferase, and viral multiplication","volume":"253","author":"Pugh","year":"1978","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.ejps.2025.107312_bib0074","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4103\/jfmpc.jfmpc_839_21","article-title":"SARS, MERS and CoVID-19: an overview and comparison of clinical, laboratory and radiological features","volume":"11","author":"Pustake","year":"2022","journal-title":"J. Fam. Med. Prim. Care"},{"issue":"2","key":"10.1016\/j.ejps.2025.107312_bib0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.mbm.2023.100015","article-title":"In silico study unfolds inhibitory potential of epicatechin gallate against SARS-CoV-2 entry and replication within the host cell","volume":"1","author":"Rajak","year":"2023","journal-title":"Mechanobiol. Med."},{"issue":"5","key":"10.1016\/j.ejps.2025.107312_bib0076","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.molcel.2020.07.027","article-title":"Coronavirus RNA proofreading: molecular basis and therapeutic targeting","volume":"79","author":"Robson","year":"2020","journal-title":"Mol. Cell"},{"issue":"2","key":"10.1016\/j.ejps.2025.107312_bib0077","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0022-1759(91)90114-U","article-title":"An improved colorimetric assay for cell proliferation and viability utilizing the tetrazolium salt XTT","volume":"142","author":"Roehm","year":"1991","journal-title":"J. Immunol. Methods"},{"issue":"1","key":"10.1016\/j.ejps.2025.107312_bib0078","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2023.2204164","article-title":"A universal fluorescence polarization high throughput screening assay to target the SAM-binding sites of SARS-CoV-2 and other viral methyltransferases","volume":"12","author":"Samrat","year":"2023","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.ejps.2025.107312_bib0079","first-page":"1","article-title":"Structure-based virtual screening and molecular dynamics simulation of SARS-CoV-2 guanine-N7 methyltransferase (nsp14) for identifying antiviral inhibitors against COVID-19","author":"Selvaraj","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.ejps.2025.107312_bib0080","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1038\/s41467-023-38019-1","article-title":"Discovery and structural characterization of monkeypox virus methyltransferase VP39 inhibitors reveal similarities to SARS-CoV-2 nsp14 methyltransferase","volume":"14","author":"Silhan","year":"2023","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.ejps.2025.107312_bib0081","doi-asserted-by":"crossref","first-page":"7785","DOI":"10.1021\/acs.jmedchem.2c02120","article-title":"Structure-based discovery of inhibitors of the SARS-CoV-2 Nsp14 N7-methyltransferase","volume":"66","author":"Singh","year":"2023","journal-title":"J. Med. Chem."},{"issue":"8","key":"10.1016\/j.ejps.2025.107312_bib0082","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003565","article-title":"Coronaviruses lacking exoribonuclease activity are susceptible to lethal mutagenesis: evidence for proofreading and potential therapeutics","volume":"9","author":"Smith","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ejps.2025.107312_bib0083","first-page":"1","article-title":"In silico evaluation of S-adenosyl-L-homocysteine analogs as inhibitors of nsp14-viral cap N7 methyltranferase and PLpro of SARS-CoV-2: synthesis, molecular docking, physicochemical data, ADMET and molecular dynamics simulations studies","author":"Srivastava","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"30","key":"10.1016\/j.ejps.2025.107312_bib0084","doi-asserted-by":"crossref","first-page":"27410","DOI":"10.1021\/acsomega.3c02815","article-title":"Rational design of highly potent SARS-CoV-2 nsp14 methyltransferase inhibitors","volume":"8","author":"\u0160tefek","year":"2023","journal-title":"ACS Omega"},{"issue":"656","key":"10.1016\/j.ejps.2025.107312_bib0085","doi-asserted-by":"crossref","first-page":"eabo0718","DOI":"10.1126\/scitranslmed.abo0718","article-title":"Mutations in the SARS-CoV-2 RNA-dependent RNA polymerase confer resistance to remdesivir by distinct mechanisms","volume":"14","author":"Stevens","year":"2022","journal-title":"Sci. Transl. Med."},{"issue":"3","key":"10.1016\/j.ejps.2025.107312_bib0086","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.apsb.2020.08.011","article-title":"Diversity of the reaction mechanisms of SAM-dependent enzymes","volume":"11","author":"Sun","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"issue":"7","key":"10.1016\/j.ejps.2025.107312_bib0087","doi-asserted-by":"crossref","first-page":"4258","DOI":"10.1002\/jmv.27009","article-title":"Coronavirus genomic nsp14-ExoN, structure, role, mechanism, and potential application as a drug target","volume":"93","author":"Tahir","year":"2021","journal-title":"J. Med. Virol."},{"issue":"9","key":"10.1016\/j.ejps.2025.107312_bib0088","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.35431","article-title":"Emerging SARS-CoV-2 resistance after antiviral treatment","volume":"7","author":"Tamura","year":"2024","journal-title":"JAMA Netw. Open"},{"issue":"1","key":"10.1016\/j.ejps.2025.107312_bib0089","doi-asserted-by":"crossref","first-page":"9801","DOI":"10.1038\/s41598-024-58532-7","article-title":"Cheminformatics approach to identify andrographolide derivatives as dual inhibitors of methyltransferases (nsp14 and nsp16) of SARS-CoV-2","volume":"14","author":"Thomas","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejps.2025.107312_bib0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2021.105137","article-title":"Preclinical evaluation of Imatinib does not support its use as an antiviral drug against SARS-CoV-2","volume":"193","author":"Touret","year":"2021","journal-title":"Antivir. Res."},{"issue":"1","key":"10.1016\/j.ejps.2025.107312_bib0091","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s43141-021-00120-7","article-title":"Molecular docking studies of some selected gallic acid derivatives against five non-structural proteins of novel coronavirus","volume":"19","author":"Umar","year":"2021","journal-title":"J. Genet. Eng. Biotechnol."},{"issue":"21","key":"10.1016\/j.ejps.2025.107312_bib0092","doi-asserted-by":"crossref","first-page":"10423","DOI":"10.1093\/nar\/gkw637","article-title":"Molecular basis of RNA guanine-7 methyltransferase (RNMT) activation by RAM","volume":"44","author":"Varshney","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejps.2025.107312_bib0093","unstructured":"Veklury | European Medicines Agency. Retrieved 2 January 2024, from https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/veklury."},{"issue":"3","key":"10.1016\/j.ejps.2025.107312_bib0094","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41579-020-00468-6","article-title":"Coronavirus biology and replication: implications for SARS-CoV-2","volume":"19","author":"V\u2019kovski","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"issue":"3","key":"10.1016\/j.ejps.2025.107312_bib0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.arabjc.2024.105614","article-title":"First report on the QSAR modelling and multistep virtual screening of the inhibitors of nonstructural protein Nsp14 of SARS-CoV-2: reducing unnecessary chemical synthesis and experimental tests","volume":"17","author":"Wang","year":"2024","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.ejps.2025.107312_bib0096","doi-asserted-by":"crossref","unstructured":"Wang, X., Sacramento, C.Q., Jockusch, S., Chaves, O.A., Tao, C., Fintelman-Rodrigues, N., Chien, M., Temerozo, J.R., Li, X., Kumar, S., Xie, W., Patel, D.J., Meyer, C., Garzia, A., Tuschl, T., Bozza, P.T., Russo, J.J., Souza, T.M.L., & Ju, J. (2021). Combination of antiviral drugs to inhibit SARS-CoV-2 polymerase and exonuclease as potential COVID-19 therapeutics (p. 2021.07.21.453274). bioRxiv. 10.1101\/2021.07.21.453274.","DOI":"10.1101\/2021.07.21.453274"},{"issue":"12","key":"10.1016\/j.ejps.2025.107312_bib0097","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0260958","article-title":"Niclosamide shows strong antiviral activity in a human airway model of SARS-CoV-2 infection and a conserved potency against the alpha (B.1.1.7), Beta (B.1.351) and Delta variant (B.1.617.2)","volume":"16","author":"Weiss","year":"2021","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ejps.2025.107312_bib0098","doi-asserted-by":"crossref","DOI":"10.1021\/acsinfecdis.4c01044","article-title":"Identification and evaluation of non-nucleosidic MTase inhibitors against SARS-CoV-2 nsp14 with lower-micromolar anti-coronavirus activity","author":"Wen","year":"2025","journal-title":"ACS Infect. Dis."},{"issue":"10","key":"10.1016\/j.ejps.2025.107312_bib0099","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.3390\/molecules29102312","article-title":"Structure-based virtual screening for methyltransferase inhibitors of SARS-CoV-2 nsp14 and nsp16","volume":"29","author":"Wu","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.ejps.2025.107312_bib0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2025.130110","article-title":"Nucleoside antiviral agents with atypical structures and new targets","volume":"119","author":"Xu","year":"2025","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejps.2025.107312_bib0101","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.117103","article-title":"PRMT7 in cancer: structure, effects, and therapeutic potentials","volume":"283","author":"Yang","year":"2025","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejps.2025.107312_bib0102","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1039\/C8MD00474A","article-title":"Design and synthesis of heteroaromatic-based benzenesulfonamide derivatives as potent inhibitors of H5N1 influenza A virus","volume":"10","author":"Yu","year":"2019","journal-title":"MedChemComm"},{"key":"10.1016\/j.ejps.2025.107312_bib0103","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2023.105714","article-title":"Inhibitors of mpox VP39 2\u2032-O methyltransferase efficiently inhibit the monkeypox virus","volume":"218","author":"Zgarbov\u00e1","year":"2023","journal-title":"Antivir. Res."},{"issue":"3","key":"10.1016\/j.ejps.2025.107312_bib0104","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1021\/acschembio.5b00812","article-title":"SAM\/SAH analogs as versatile tools for SAM-dependent methyltransferases","volume":"11","author":"Zhang","year":"2016","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejps.2025.107312_bib0105","article-title":"Structure of SARS-CoV-2 MTase nsp14 with the inhibitor STM957 reveals inhibition mechanism that is shared with a poxviral MTase VP39","volume":"10","author":"Zilecka","year":"2024","journal-title":"J. Struct. Biol. X"},{"issue":"1","key":"10.1016\/j.ejps.2025.107312_bib0106","doi-asserted-by":"crossref","first-page":"9161","DOI":"10.1038\/s41598-023-35907-w","article-title":"Ebselen derivatives inhibit SARS-CoV-2 replication by inhibition of its essential proteins: PLpro and Mpro proteases, and nsp14 guanine N7-methyltransferase","volume":"13","author":"Zmudzinski","year":"2023","journal-title":"Sci. Rep."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098725003100?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098725003100?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T03:57:50Z","timestamp":1778558270000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098725003100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":106,"alternative-id":["S0928098725003100"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2025.107312","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SARS-CoV-2 N7-methyltransferase inhibitors: Towards selective and potent antivirals","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2025.107312","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107312"}}